|
1
|
Cheng YS, Champliaud MF, Burgeson RE,
Marinkovich MP and Yurchenco PD: Self-assembly of laminin isoforms.
J Biol Chem. 272:31525–31532. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lugassy C, Torres-Munoz JE, Kleinman HK,
Ghanem G, Vernon S and Barnhill RL: Overexpression of
malignancy-associated laminins and laminin receptors by angiotropic
human melanoma cells in a chick chorioallantoic membrane model. J
Cutan Pathol. 36:1237–1243. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Caldeira J, Figueiredo J, Bras-Pereira C,
Carneiro P, Moreira AM, Pinto MT, Relvas JB, Carneiro F, Barbosa M,
Casares F, et al: E-cadherin-defective gastric cancer cells depend
on Laminin to survive and invade. Hum Mol Genet. 24:5891–5900.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ii M, Yamamoto H, Taniguchi H, Adachi Y,
Nakazawa M, Ohashi H, Tanuma T, Sukawa Y, Suzuki H, Sasaki S, et
al: Co-expression of laminin beta3 and gamma2 chains and epigenetic
inactivation of laminin alpha3 chain in gastric cancer. Int J
Oncol. 39:593–599. 2011.PubMed/NCBI
|
|
5
|
Shan N, Zhang X, Xiao X, Zhang H, Tong C,
Luo X, Chen Y, Liu X, Yin N, Deng Q and Qi H: Laminin alpha4
(LAMA4) expression promotes trophoblast cell invasion, migration,
and angiogenesis, and is lowered in preeclamptic placentas.
Placenta. 36:809–820. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang X, Ji G, Wu Y, Wan B and Yu L:
LAMA4, highly expressed in human hepatocellular carcinoma from
Chinese patients, is a novel marker of tumor invasion and
metastasis. J Cancer Res Clin Oncol. 134:705–714. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ross JB, Huh D, Noble LB and Tavazoie SF:
Identification of molecular determinants of primary and metastatic
tumour re-initiation in breast cancer. Nat Cell Biol. 17:651–664.
2015. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wragg JW, Finnity JP, Anderson JA,
Ferguson HJ, Porfiri E, Bhatt RI, Murray PG, Heath VL and Bicknell
R: MCAM and LAMA4 are highly enriched in tumor blood vessels of
fenal cell carcinoma and predict patient outcome. Cancer Res.
76:2314–2326. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Spaderna S, Schmalhofer O, Wahlbuhl M,
Dimmler A, Bauer K, Sultan A, Hlubek F, Jung A, Strand D and Eger
A: The transcriptional repressor ZEB1 promotes metastasis and loss
of cell polarity in cancer. Cancer Res. 68:537–544. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wellner U, Schubert J, Burk UC,
Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D,
zur Hausen A, et al: The EMT-activator ZEB1 promotes tumorigenicity
by repressing stemness-inhibiting microRNAs. Nat Cell Biol.
11:1487–1495. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guo E, Wang Z and Wang S: MiR-200c and
miR-141 inhibit ZEB1 synergistically and suppress glioma cell
growth and migration. Eur Rev Med Pharmacol Sci. 20:3385–3391.
2016.PubMed/NCBI
|
|
12
|
Okugawa Y, Toiyama Y, Tanaka K, Matsusita
K, Fujikawa H, Saigusa S, Ohi M, Inoue Y, Mohri Y, Uchida K and
Kusunoki M: Clinical significance of Zinc finger E-box Binding
homeobox 1 (ZEB1) in human gastric cancer. J Surg Oncol.
106:280–285. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jia B, Liu H, Kong Q and Li B:
Overexpression of ZEB1 associated with metastasis and invasion in
patients with gastric carcinoma. Mol Cell Biochem. 366:223–229.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hur K, Toiyama Y, Takahashi M, Balaguer F,
Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR and Goel A:
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT)
in human colorectal cancer metastasis. Gut. 62:1315–1326. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou X, Wang Y, Shan B, Han J, Zhu H, Lv
Y, Fan X, Sang M, Liu XD and Liu W: The downregulation of
miR-200c/141 promotes ZEB1/2 expression and gastric cancer
progression. Med Oncol. 32:4282015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yanaka Y, Muramatsu T, Uetake H, Kozaki K
and Inazawa J: miR-544a induces epithelial-mesenchymal transition
through the activation of WNT signaling pathway in gastric cancer.
Carcinogenesis. 36:1363–1371. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sanchez-Tillo E, Liu Y, de Barrios O,
Siles L, Fanlo L, Cuatrecasas M, Darling DS, Dean DC, Castells A
and Postigo A: EMT-activating transcription factors in cancer:
Beyond EMT and tumor invasiveness. Cell Mol Life Sci. 69:3429–3456.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Postigo AA and Dean DC: ZEB represses
transcription through interaction with the corepressor CtBP. Proc
Natl Acad Sci USA. 96:6683–6688. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Larsen JE, Nathan V, Osborne JK, Farrow
RK, Deb D, Sullivan JP, Dospoy PD, Augustyn A, Hight SK and Sato M:
ZEB1 drives epithelial-to-mesenchymal transition in lung cancer. J
Clin Invest. 126:3219–3235. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lindskog C: The potential clinical impact
of the tissue-based map of the human proteome. Expert Rev
Proteomics. 12:213–215. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Szász AM, Lánczky A, Nagy Á, Förster S,
Hark K, Green JE, Boussioutas A, Busuttil R, Szabó A and Győrffy B:
Cross-validation of survival associated biomarkers in gastric
cancer using transcriptomic data of 1,065 patients. Oncotarget.
7:49322–49333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yabusaki N, Yamada S, Murai T, Kanda M,
Kobayashi D, Tanaka C, Fujii T, Nakayama G, Sugimoto H, Koike M, et
al: Clinical significance of zinc-finger E-box binding homeobox 1
mRNA levels in peritoneal washing for gastric cancer. Mol Clin
Oncol. 3:435–441. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sato H and Seiki M: Membrane-type matrix
metalloproteinases (MT-MMPs) in tumor metastasis. J Biochem.
119:209–215. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yasui W, Oue N, Aung PP, Matsumura S,
Shutoh M and Nakayama H: Molecular-pathological prognostic factors
of gastric cancer: A review. Gastric Cancer. 8:86–94. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ferretti C, Bruni L, Dangles-Marie V,
Pecking AP and Bellet D: Molecular circuits shared by placental and
cancer cells, and their implications in the proliferative, invasive
and migratory capacities of trophoblasts. Hum Reprod Update.
13:121–141. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Miao L, Xiong X, Lin Y, Cheng Y, Lu J,
Zhang J and Cheng N: Down-regulation of FoxM1 leads to the
inhibition of the epithelial-mesenchymal transition in gastric
cancer cells. Cancer Genet. 207:75–82. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu L, Tong Q, Liu S, Cui J, Zhang Q, Sun
W and Yang S: ZEB1 upregulates VEGF expression and stimulates
angiogenesis in breast cancer. PLoS One. 11:e01487742016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou C, Jiang H, Zhang Z, Zhang G, Wang H,
Zhang Q, Sun P, Xiang R and Yang S: ZEB1 confers stem cell-like
properties in breast cancer by targeting neurogenin-3. Oncotarget.
8:54388–54401. 2017.PubMed/NCBI
|
|
30
|
Zheng G, Peng C, Jia X, Gu Y, Zhang Z,
Deng Y, Wang C, Li N, Yin J, Liu X, et al: ZEB1 transcriptionally
regulated carbonic anhydrase 9 mediates the chemoresistance of
tongue cancer via maintaining intracellular pH. Mol Cancer.
14:842015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Adachi Y, Takeuchi T, Nagayama T, Ohtsuki
Y and Furihata M: Zeb1-mediated T-cadherin repression increases the
invasive potential of gallbladder cancer. FEBS Lett. 583:430–436.
2009. View Article : Google Scholar : PubMed/NCBI
|
